Sort   by:  
 Page size 
UnknownCangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial.
Not available
S-EPMC11472137 | biostudies-literature
TranscriptomicsTranscription profiling of vastus lateralis muscle from healthy young (21-31 year old) and older (62-77 year old) men
RNA from vastus lateralis of healthy young (21-31 year old) and older (62-77 year old) men. Signal data normalized to mean intensity of 500 over all probes sets. Analysis done with Affymetrix Microarray Suite 5.0 software.
ORGANISM(S): Homo sapiens 
2007-10-30 | E-GEOD-80 | biostudies-arrayexpress
UnknownElectronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical Trials.
Not available
S-EPMC11571070 | biostudies-literature
UnknownTwenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction.
Not available
S-EPMC6380926 | biostudies-literature
TranscriptomicsGene expression changes during resistance toward vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI) therapy in renal cell carcinoma (RCC)
This study was performed to understand the gene expression changes that accompany treatment of renal cell carcinoma (RCC) with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI) therapy. Human RCC cell lines were implanted into the flanks of nude beige mice, allowed...
ORGANISM(S): Homo sapiens 
2015-05-21 | E-GEOD-64052 | biostudies-arrayexpress
UnknownLongitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Not available
S-EPMC4871817 | biostudies-literature
TranscriptomicsComplete hematologic response of early-T-cell progenitor acute lymphoblastic leukemia to the gamma-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case
Notch pathway antagonists such as gamma-secretase inhibitors (GSI) are being tested in diverse cancers, but exceptional responses have yet to be reported. We describe the case of a patient with relapsed/refractory early-T-cell progenitor acute lymphoblastic leukemia (ETP-ALL) who achieved a complete...
ORGANISM(S): Homo sapiens 
2015-07-29 | E-GEOD-71414 | biostudies-arrayexpress
Sort   by:  
 Page size